Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?

Literature DB >> 11907017

Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?

N Cromie, C Lee, A D Struthers.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 11907017 PMCID： PMC1767058 DOI： 10.1136/heart.87.4.377

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

3 in total

1. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

Authors: D S Silverberg; D Wexler; D Sheps; M Blum; G Keren; R Baruch; D Schwartz; T Yachnin; S Steinbruch; I Shapira; S Laniado; A Iaina
Journal: J Am Coll Cardiol Date: 2001-06-01 Impact factor: 24.094

2. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Authors: D S Silverberg; D Wexler; M Blum; G Keren; D Sheps; E Leibovitch; D Brosh; S Laniado; D Schwartz; T Yachnin; I Shapira; D Gavish; R Baruch; B Koifman; C Kaplan; S Steinbruch; A Iaina
Journal: J Am Coll Cardiol Date: 2000-06 Impact factor: 24.094

3. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

Authors: A Al-Ahmad; W M Rand; G Manjunath; M A Konstam; D N Salem; A S Levey; M J Sarnak
Journal: J Am Coll Cardiol Date: 2001-10 Impact factor: 24.094

3 in total

7 in total

1. Anaemia and heart failure.

Authors: A J S Coats
Journal: Heart Date: 2004-09 Impact factor: 5.994

2. Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.

Authors: Simon de Denus; Jean-Claude Tardif; Michel White; Martial G Bourassa; Normand Racine; Sylvie Levesque; Anique Ducharme
Journal: Can J Cardiol Date: 2008-01 Impact factor: 5.223

Review 3. Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.

Authors: Qurat-ul-ain Jelani; Stuart D Katz
Journal: Cardiol Rev Date: 2010 Sep-Oct Impact factor: 2.644

Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?

1. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

2. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

3. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

1. Anaemia and heart failure.

2. Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.

Review 3. Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.

Review 4. Heart failure and anemia: mechanisms and pathophysiology.

Review 5. The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes.

6. Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.

7. The influence of anemia on one-year exacerbation rate of patients with COPD-PH.